🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
To explore the efficacy and safety of vebreltinib plus platinum-doublet che...
Status
Not Yet Recruiting
Location
241 West Huaihai Road, Xuhui District, Shanghai, 200030, China.
Start Date
2026-03-30
Trial ID
NCT07549061
Treatments Being Tested
The purpose of this study is to determine if the use of exploratory immunol...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Start Date
2013-07-05
Trial ID
NCT01899989
Treatments Being Tested
Immunotherapeutic approaches recently have demonstrated clinical efficacy i...
Status
Recruiting
Location
Aix-en-Provence - CH
Start Date
2022-05-02
Trial ID
NCT05255302
Treatments Being Tested
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
This is a nonrandomized, open phase I dose escalation and extension clinica...
Status
Unknown
Location
Zhangli
Start Date
2022-09-21
Trial ID
NCT05489731
Treatments Being Tested
Chemotherapeutic agents exert significant immunomodulatory effects by influ...
Status
Recruiting
Location
the First Affiliated Hospital of Zhengzhou University
Start Date
2025-06-01
Trial ID
NCT06896422
Treatments Being Tested
This is a multicenter, prospective, single-arm, phase 2 clinical trial desi...
Status
Recruiting
Location
Anhui Provincial Cancer Hospital
Start Date
2024-09-12
Trial ID
NCT06288360
Treatments Being Tested
In clinical practice, some patients cannot tolerate concurrent chemoradioth...
Status
Recruiting
Location
Zibo Municipal Hospital
Start Date
2024-01-13
Trial ID
NCT07085182
Treatments Being Tested
This Observational study will explore the utility of the Biodesix, Inc. "PI...
Status
Terminated
Location
Addario Lung Cancer Medical Institute (ALCMI)
Start Date
2021-02-01
Trial ID
NCT04676386
Treatments Being Tested